204 related articles for article (PubMed ID: 19066958)
1. Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King's College Hospital and review of the literature.
Taylor RM; Chen Y; Dhawan A;
Eur J Pediatr; 2009 Sep; 168(9):1061-8. PubMed ID: 19066958
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
[TBL] [Abstract][Full Text] [Related]
4. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
5. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
[TBL] [Abstract][Full Text] [Related]
6. Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature.
Boga S; Jain D; Schilsky ML
BMC Pharmacol Toxicol; 2015 Nov; 16():30. PubMed ID: 26589720
[TBL] [Abstract][Full Text] [Related]
7. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment.
Arnon R; Calderon JF; Schilsky M; Emre S; Shneider BL
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):596-602. PubMed ID: 17460493
[TBL] [Abstract][Full Text] [Related]
8. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
Leung M; Wu Lanzafame J; Medici V
J Investig Med High Impact Case Rep; 2020; 8():2324709619896876. PubMed ID: 31920114
[No Abstract] [Full Text] [Related]
9. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Dathe K; Beck E; Schaefer C
Reprod Toxicol; 2016 Oct; 65():39-45. PubMed ID: 27350316
[TBL] [Abstract][Full Text] [Related]
10. [Wilson disease: an update].
Seo JK
Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
[TBL] [Abstract][Full Text] [Related]
11. Wilson disease.
El-Youssef M
Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
[TBL] [Abstract][Full Text] [Related]
13. Wilson disease in 71 patients followed for over two decades in a tertiary center in Saudi Arabia: a retrospective review.
Al Fadda M; Al Quaiz M; Al Ashgar H; Al Kahtani K; Helmy A; Al Benmousa A; Abdulla M; Peedikayil M
Ann Saudi Med; 2012; 32(6):623-9. PubMed ID: 23396027
[TBL] [Abstract][Full Text] [Related]
14. Treatment and management of Wilson's disease.
Shimizu N; Yamaguchi Y; Aoki T
Pediatr Int; 1999 Aug; 41(4):419-22. PubMed ID: 10453198
[TBL] [Abstract][Full Text] [Related]
15. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
Dubois RS; Rodgerson DO; Hambidge KM
J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Schilsky ML
Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
[TBL] [Abstract][Full Text] [Related]
18. Wilson Disease in Children.
Kerkar N; Rana A
Clin Liver Dis; 2022 Aug; 26(3):473-488. PubMed ID: 35868686
[TBL] [Abstract][Full Text] [Related]
19. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.
Seessle J; Gotthardt DN; Schäfer M; Gohdes A; Pfeiffenberger J; Ferenci P; Stremmel W; Weiss KH
J Inherit Metab Dis; 2016 Jan; 39(1):125-30. PubMed ID: 26067812
[TBL] [Abstract][Full Text] [Related]
20. Triethylene-tetramine (trien) therapy for Wilson's disease.
Saito H; Watanabe K; Sahara M; Mochizuki R; Edo K; Ohyama Y
Tohoku J Exp Med; 1991 May; 164(1):29-35. PubMed ID: 1926144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
